Company profilePharmaceutical#353 of 1,318 in Pakistan2 DRAP alerts

CHIESI PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 48 brands · 34 molecules

Ranked #3 of 17 companies in Respiratory Care

48 registered products 35 pharmaceutical brands 34 distinct molecules 2 DRAP alerts

Company overview

48
registered products
35
pharmaceutical brands
34
distinct molecules
11
therapeutic classes
2
DRAP alerts

CHIESI PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 48 product registrations across 34 distinct molecules. Its portfolio is concentrated in Respiratory Care and Drugs For Obstructive Airway Diseases, Inhalants. DRAP has issued 2 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by CHIESI

30 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Drugs For Obstructive Airway Diseases, Systemic 2
Antiinflammatory And Antirheumatic Products 2

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

3
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20263

Top molecules by brand count

Nebuliser3 brands
Albuterol3 brands
Caffeine2 brands
Nasal Spray2 brands
Piroxicam Topical2 brands
Formoterol2 brands

Therapeutic classes

Respiratory Care · 10Drugs For Obstructive Airway Diseases, Inhalants · 7Drugs For Obstructive Airway Diseases, Systemic · 2Lung Surfactants · 2Pain Management · 2Antiinflammatory And Antirheumatic Products · 2Quinolone Antibacterials · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Agents Against Amoebiasis And Other Protozoal Diseases · 1Allergy · 1Topical Products For Joint And Muscular Pain · 1

Conditions treated

Asthma/Copd · 9Pain Killers · 2Asthma/Allergy · 1Nasal Congestion · 1Gout · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official10 products · Rs 430.29 – Rs 58,245
DVAGO12 products · Rs 137.1 – Rs 37,392
Servaid14 products · Rs 112 – Rs 27,524
Median across source: Rs 1,127.62

Regulatory record

2 alerts in the DRAP feed we track.

31. Rapid Alert – SPURIOUS / FALSIFIED BREXIN TABLETS 20 mg
2026-06-02
19. Recall Alert – WHO Recall Class-II
2026-04-14

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GETZ PHARMA PAKISTAN (PVT) LTD. holds 266 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
HIGHNOON LABORATORIES LIMITED holds 159 molecules not in this portfolio
000 I.U5-Fluorouracil 500MgAceclofenacAcyclovirAcyclovir Inf/OralAmlodipine
Atco Pharma International (Pvt) Ltd holds 228 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAminophyllineAmlodipine

Get the full profile for CHIESI

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.